| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.957 | 0.002 | 0.957 | Aldehyde oxidase inhibitor | 0.631 0.015 DBMET00364 | ||
| 0.743 | 0.003 | 0.743 | Dopamine D4 antagonist | 0.194 0.013 DBMET00364 | ||
| 0.705 | 0.004 | 0.705 | Dopamine antagonist | 0.217 0.017 DBMET00364 | ||
| 0.679 | 0.004 | 0.679 | 5 Hydroxytryptamine antagonist | 0.215 0.031 DBMET00364 | ||
| 0.678 | 0.004 | 0.678 | Alpha adrenoreceptor antagonist | 0.24 0.021 DBMET00364 | ||
| 0.658 | 0.004 | 0.658 | Alpha 1 adrenoreceptor antagonist | 0.211 0.019 DBMET00364 | ||
| 0.642 | 0.004 | 0.642 | Dopamine D2 antagonist | 0.151 0.022 DBMET00364 | ||
| 0.624 | 0.004 | 0.624 | Alpha 1a adrenoreceptor antagonist | 0.193 0.017 DBMET00364 | ||
| 0.582 | 0.003 | 0.582 | Alpha 1b adrenoreceptor antagonist | 0.207 0.014 DBMET00364 | ||
| 0.569 | 0.003 | 0.569 | Acetylcholine agonist | 0.199 0.014 DBMET00364 | ||
| 0.558 | 0.009 | 0.558 | Anticonvulsant | |||
| 0.541 | 0.005 | 0.541 | 5 Hydroxytryptamine 2 antagonist | 0.135 0.05 DBMET00364 | ||
| 0.516 | 0.005 | 0.516 | 5 Hydroxytryptamine 2B antagonist | 0.174 0.032 DBMET00364 | ||
| 0.5 | 0.002 | 0.5 | Acetylcholine muscarinic agonist | 0.156 0.009 DBMET00364 | ||
| 0.5 | 0.003 | 0.5 | 5 Hydroxytryptamine 3 antagonist | 0.204 0.005 DBMET00364 | ||
| 0.511 | 0.025 | 0.511 | Histamine release inhibitor | |||
| 0.469 | 0.002 | 0.469 | Acetylcholine M1 receptor agonist | 0.143 0.008 DBMET00364 | ||
| 0.466 | 0.005 | 0.466 | 5 Hydroxytryptamine 2A antagonist | 0.082 0.058 DBMET00364 | ||
| 0.463 | 0.005 | 0.463 | 5 Hydroxytryptamine 1A antagonist | 0.081 0.04 DBMET00364 | ||
| 0.496 | 0.05 | 0.496 | Analgesic | 0.285 0.154 DBMET00364 | ||
| 0.443 | 0.005 | 0.443 | Antihistaminic | 0.115 0.045 DBMET00364 | ||
| 0.44 | 0.002 | 0.44 | 5 Hydroxytryptamine 3B antagonist | 0.051 0.014 DBMET00364 | ||
| 0.439 | 0.004 | 0.439 | 5 Hydroxytryptamine 1E antagonist | 0.294 0.034 DBMET00364 | ||
| 0.439 | 0.005 | 0.439 | 5 Hydroxytryptamine 7 antagonist | 0.239 0.009 DBMET00364 | ||
| 0.437 | 0.004 | 0.437 | Dopamine D3 antagonist | 0.124 0.019 DBMET00364 | ||
| 0.434 | 0.005 | 0.434 | Histamine antagonist | 0.106 0.045 DBMET00364 | ||
| 0.426 | 0.003 | 0.501 | Nociceptin (N/OFQ) receptor antagonist | 0.501 0.003 DBMET00364 | DBMET00364 | |
| 0.426 | 0.004 | 0.426 | Alpha 1d adrenoreceptor antagonist | 0.132 0.017 DBMET00364 | ||
| 0.426 | 0.005 | 0.426 | 5 Hydroxytryptamine 1 antagonist | 0.07 0.054 DBMET00364 | ||
| 0.41 | 0.002 | 0.41 | 5 Hydroxytryptamine 3A antagonist | 0.117 0.01 DBMET00364 | ||
| 0.409 | 0.004 | 0.409 | Histamine H1 receptor antagonist | 0.124 0.031 DBMET00364 | ||
| 0.398 | 0.005 | 0.398 | 5 Hydroxytryptamine 2C antagonist | 0.152 0.026 DBMET00364 | ||
| 0.385 | 0.004 | 0.385 | Dopamine D1 antagonist | 0.306 0.005 DBMET00364 | ||
| 0.405 | 0.027 | 0.405 | HERG channel blocker | 0.189 0.097 DBMET00364 | ||
| 0.371 | 0.002 | 0.371 | 5 Hydroxytryptamine 3A agonist | 0.293 0.004 DBMET00364 | ||
| 0.392 | 0.023 | 0.392 | Sigma receptor agonist | |||
| 0.378 | 0.009 | 0.378 | Antiadrenergic | 0.127 0.043 DBMET00364 | ||
| 0.375 | 0.009 | 0.375 | Adrenaline antagonist | 0.125 0.042 DBMET00364 | ||
| 0.369 | 0.012 | 0.369 | Cholinergic | 0.189 0.051 DBMET00364 | ||
| 0.345 | 0.009 | 0.345 | Acetylcholine M1 receptor antagonist | 0.31 0.013 DBMET00364 | ||
| 0.34 | 0.004 | 0.34 | Alpha 1 adrenoreceptor agonist | 0.143 0.01 DBMET00364 | ||
| 0.32 | 0.002 | 0.32 | Acetylcholine M4 receptor agonist | 0.056 0.01 DBMET00364 | ||
| 0.324 | 0.007 | 0.324 | Nav1.1 sodium channel blocker | 0.098 0.068 DBMET00364 | ||
| 0.316 | 0.005 | 0.316 | Toll-Like receptor antagonist | 0.247 0.016 DBMET00364 | ||
| 0.335 | 0.03 | 0.335 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.334 | 0.04 | 0.334 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.299 | 0.006 | 0.299 | Alpha 2c adrenoreceptor antagonist | 0.14 0.037 DBMET00364 | ||
| 0.296 | 0.009 | 0.296 | Alpha 2b adrenoreceptor antagonist | 0.21 0.021 DBMET00364 | ||
| 0.286 | 0.016 | 0.286 | Nav1.2 sodium channel blocker | 0.184 0.041 DBMET00364 | ||
| 0.266 | 0.002 | 0.266 | 5 Hydroxytryptamine 4 antagonist | 0.087 0.01 DBMET00364 | ||
| 0.283 | 0.025 | 0.283 | Diuretic | 0.142 0.083 DBMET00364 | ||
| 0.254 | 0.003 | 0.254 | Acetylcholine M3 receptor agonist | 0.214 0.004 DBMET00364 | ||
| 0.236 | 0.007 | 0.236 | Dopamine agonist | 0.073 0.042 DBMET00364 | ||
| 0.236 | 0.01 | 0.236 | NMDA receptor antagonist | 0.235 0.01 DBMET00364 | ||
| 0.229 | 0.007 | 0.229 | Alpha adrenoreceptor agonist | 0.19 0.01 DBMET00364 | ||
| 0.22 | 0.002 | 0.22 | Acetylcholine M5 receptor agonist | 0.11 0.015 DBMET00364 | ||
| 0.221 | 0.003 | 0.221 | Acetylcholine M2 receptor agonist | 0.124 0.005 DBMET00364 | ||
| 0.208 | 0.005 | 0.208 | Dopamine D5 antagonist | 0.183 0.005 DBMET00364 | ||
| 0.215 | 0.015 | 0.215 | Alpha 2 adrenoreceptor antagonist | 0.119 0.037 DBMET00364 | ||
| 0.198 | 0.001 | 0.198 | Phospholipase D inhibitor | 0.195 0.001 DBMET00364 | ||
| 0.2 | 0.007 | 0.2 | Dopamine D4 agonist | |||
| 0.197 | 0.006 | 0.197 | Acetylcholine M4 receptor antagonist | 0.1 0.028 DBMET00364 | ||
| 0.195 | 0.01 | 0.195 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.24 | 0.056 | 0.24 | RNA-directed DNA polymerase inhibitor | |||
| 0.204 | 0.023 | 0.204 | Acetylcholine muscarinic antagonist | 0.15 0.044 DBMET00364 | ||
| 0.18 | 0.002 | 0.18 | Calcitonin gene-related peptide 1 receptor antagonist | 0.161 0.002 DBMET00364 | ||
| 0.2 | 0.036 | 0.2 | Toll-Like receptor 9 antagonist | 0.164 0.054 DBMET00364 | ||
| 0.161 | 0.002 | 0.161 | Calcitonin gene-related peptide antagonist | 0.103 0.003 DBMET00364 | ||
| 0.158 | 0.003 | 0.158 | Nociceptin (N/OFQ) receptor agonist | 0.156 0.003 DBMET00364 | ||
| 0.245 | 0.094 | 0.245 | Spasmolytic | |||
| 0.18 | 0.03 | 0.195 | Neuropeptide Y1 antagonist | 0.195 0.021 DBMET00364 | DBMET00364 | |
| 0.16 | 0.012 | 0.16 | 5 Hydroxytryptamine 1B antagonist | 0.072 0.039 DBMET00364 | ||
| 0.153 | 0.005 | 0.195 | 5 Hydroxytryptamine 3 agonist | 0.195 0.004 DBMET00364 | DBMET00364 | |
| 0.149 | 0.003 | 0.149 | CC chemokine 4 receptor antagonist | 0.062 0.014 DBMET00364 | ||
| 0.164 | 0.02 | 0.164 | DNA directed RNA polymerase inhibitor | |||
| 0.163 | 0.02 | 0.164 | Alpha 2a adrenoreceptor antagonist | 0.164 0.019 DBMET00364 | DBMET00364 | |
| 0.158 | 0.015 | 0.158 | NMDA 2 receptor antagonist | |||
| 0.149 | 0.008 | 0.149 | Acetylcholine M5 receptor antagonist | 0.128 0.011 DBMET00364 | ||
| 0.161 | 0.023 | 0.223 | Opioid antagonist | 0.223 0.01 DBMET00364 | DBMET00364 | |
| 0.173 | 0.041 | 0.173 | Cholinergic antagonist | 0.152 0.052 DBMET00364 | ||
| 0.243 | 0.113 | 0.243 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.211 0.145 DBMET00364 | ||
| 0.135 | 0.008 | 0.135 | Toll-Like receptor 7 antagonist | 0.12 0.012 DBMET00364 | ||
| 0.167 | 0.042 | 0.167 | Acetylcholine antagonist | 0.148 0.051 DBMET00364 | ||
| 0.145 | 0.023 | 0.145 | 5 Hydroxytryptamine agonist | 0.089 0.037 DBMET00364 | ||
| 0.152 | 0.031 | 0.152 | Chemokine receptor antagonist | |||
| 0.127 | 0.008 | 0.127 | Dopamine D2 agonist | 0.046 0.03 DBMET00364 | ||
| 0.134 | 0.015 | 0.134 | Bromodomain-containing protein 2 inhibitor | 0.118 0.024 DBMET00364 | ||
| 0.258 | 0.141 | 0.341 | Toll-Like receptor 7 agonist | 0.341 0.086 DBMET00364 | DBMET00364 | |
| 0.158 | 0.043 | 0.158 | Nav1.3 sodium channel blocker | |||
| 0.259 | 0.148 | 0.336 | Antiobesity | 0.336 0.094 DBMET00364 | DBMET00364 | |
| 0.2 | 0.09 | 0.2 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.189 0.099 DBMET00364 | ||
| 0.112 | 0.005 | 0.112 | MDM2 inhibitor | 0.096 0.008 DBMET00364 | ||
| 0.144 | 0.038 | 0.231 | Interleukin 8 antagonist | 0.231 0.007 DBMET00364 | DBMET00364 | |
| 0.241 | 0.135 | 0.241 | Vasodilator, peripheral | |||
| 0.191 | 0.085 | 0.191 | Psychostimulant | 0.158 0.11 DBMET00364 | ||
| 0.251 | 0.147 | 0.334 | Toll-Like receptor agonist | 0.334 0.09 DBMET00364 | DBMET00364 | |
| 0.112 | 0.009 | 0.112 | Neurokinin 2 antagonist | 0.085 0.013 DBMET00364 | ||
| 0.146 | 0.044 | 0.146 | MAP kinase 12 inhibitor | |||
| 0.122 | 0.021 | 0.122 | HIV-1 reverse transcriptase inhibitor | 0.101 0.03 DBMET00364 | ||
| 0.121 | 0.025 | 0.201 | Protein kinase B gamma inhibitor | 0.201 0.008 DBMET00364 | DBMET00364 | |
| 0.108 | 0.012 | 0.108 | Opioid agonist | 0.108 0.012 DBMET00364 | ||
| 0.105 | 0.01 | 0.105 | Phosphodiesterase VII inhibitor | 0.056 0.051 DBMET00364 | ||
| 0.116 | 0.025 | 0.232 | Opioid kappa receptor antagonist | 0.232 0.008 DBMET00364 | DBMET00364 | |
| 0.118 | 0.03 | 0.136 | Neuropeptide Y antagonist | 0.136 0.025 DBMET00364 | DBMET00364 | |
| 0.099 | 0.013 | 0.099 | Antidiuretic hormone antagonist | 0.04 0.027 DBMET00364 | ||
| 0.101 | 0.016 | 0.101 | Calcium channel T-type blocker | |||
| 0.112 | 0.029 | 0.112 | CC chemokine receptor antagonist | |||
| 0.107 | 0.025 | 0.127 | Nicotinic alpha4beta2 receptor antagonist | 0.127 0.014 DBMET00364 | DBMET00364 | |
| 0.163 | 0.081 | 0.163 | ATPase inhibitor | |||
| 0.288 | 0.208 | 0.288 | Caspase 9 stimulant | |||
| 0.084 | 0.008 | 0.084 | Sodium/calcium exchanger inhibitor | |||
| 0.168 | 0.091 | 0.168 | MAP kinase kinase 5 inhibitor | 0.168 0.091 DBMET00364 | ||
| 0.089 | 0.014 | 0.089 | Histamine H3 receptor antagonist | |||
| 0.077 | 0.003 | 0.077 | 5 Hydroxytryptamine 4 agonist | |||
| 0.111 | 0.037 | 0.111 | Histamine N-methyltransferase inhibitor | 0.088 0.058 DBMET00364 | ||
| 0.095 | 0.023 | 0.095 | Acetylcholine M2 receptor antagonist | 0.071 0.036 DBMET00364 | ||
| 0.085 | 0.013 | 0.085 | CC chemokine 3 receptor antagonist | |||
| 0.094 | 0.022 | 0.094 | 5 Hydroxytryptamine 1 agonist | |||
| 0.074 | 0.009 | 0.074 | Phosphodiesterase 7A inhibitor | 0.048 0.046 DBMET00364 | ||
| 0.13 | 0.065 | 0.14 | Glutamate receptor antagonist | 0.14 0.058 DBMET00364 | DBMET00364 | |
| 0.104 | 0.04 | 0.104 | Phosphodiesterase I inhibitor | 0.098 0.047 DBMET00364 | ||
| 0.195 | 0.131 | 0.238 | DNA synthesis inhibitor | 0.238 0.075 DBMET00364 | DBMET00364 | |
| 0.081 | 0.019 | 0.081 | 5 Hydroxytryptamine 1A agonist | |||
| 0.174 | 0.112 | 0.174 | Potassium channel blocker | |||
| 0.11 | 0.05 | 0.11 | Insulin receptor antagonist | 0.093 0.072 DBMET00364 | ||
| 0.066 | 0.01 | 0.066 | Kainate receptor 2 antagonist | 0.05 0.016 DBMET00364 | ||
| 0.089 | 0.033 | 0.158 | Protein kinase B beta inhibitor | 0.158 0.007 DBMET00364 | DBMET00364 | |
| 0.191 | 0.137 | 0.28 | Neuropeptide Y2 antagonist | 0.28 0.031 DBMET00364 | DBMET00364 | |
| 0.115 | 0.061 | 0.115 | MAP kinase 13 inhibitor | |||
| 0.122 | 0.069 | 0.136 | DNA repair enzyme inhibitor | 0.136 0.046 DBMET00364 | DBMET00364 | |
| 0.083 | 0.033 | 0.083 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.078 | 0.028 | 0.111 | Adrenaline uptake inhibitor | 0.111 0.016 DBMET00364 | DBMET00364 | |
| 0.079 | 0.032 | 0.079 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.085 | 0.038 | 0.128 | Opioid mu receptor antagonist | 0.128 0.023 DBMET00364 | DBMET00364 | |
| 0.064 | 0.017 | 0.064 | Neurokinin 3 antagonist | 0.052 0.026 DBMET00364 | ||
| 0.071 | 0.023 | 0.071 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.06 | 0.014 | 0.06 | Glutamate (mGluR4) antagonist | |||
| 0.099 | 0.052 | 0.189 | Protein kinase C zeta inhibitor | 0.189 0.013 DBMET00364 | DBMET00364 | |
| 0.06 | 0.014 | 0.06 | Dopamine D3 agonist | 0.037 0.03 DBMET00364 | ||
| 0.069 | 0.024 | 0.069 | Toll-Like receptor 8 antagonist | 0.066 0.027 DBMET00364 | ||
| 0.068 | 0.024 | 0.068 | Sigma receptor antagonist | |||
| 0.089 | 0.046 | 0.101 | Acetylcholine nicotinic agonist | 0.101 0.037 DBMET00364 | DBMET00364 | |
| 0.069 | 0.026 | 0.069 | NMDA 2B receptor antagonist | |||
| 0.057 | 0.015 | 0.057 | Thymidine kinase inhibitor | |||
| 0.099 | 0.058 | 0.099 | Phosphodiesterase 7B inhibitor | |||
| 0.052 | 0.013 | 0.052 | p53 inhibitor | |||
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.032 DBMET00364 | ||
| 0.096 | 0.061 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.055 | 0.02 | 0.055 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.068 | 0.035 | 0.068 | NMDA 2C receptor antagonist | |||
| 0.066 | 0.033 | 0.066 | Dopamine uptake inhibitor | |||
| 0.044 | 0.012 | 0.044 | CXC chemokine 3 receptor antagonist | |||
| 0.041 | 0.01 | 0.041 | Adenosine uptake inhibitor | |||
| 0.064 | 0.033 | 0.064 | 5 Hydroxytryptamine 6 antagonist | 0.06 0.036 DBMET00364 | ||
| 0.051 | 0.02 | 0.051 | Kainate receptor antagonist | |||
| 0.043 | 0.012 | 0.043 | Sigma 2 receptor antagonist | |||
| 0.065 | 0.035 | 0.065 | Acetylcholine M3 receptor antagonist | |||
| 0.079 | 0.049 | 0.079 | Analgesic, opioid | |||
| 0.105 | 0.077 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.056 | 0.028 | 0.058 | Neurokinin antagonist | 0.058 0.026 DBMET00364 | DBMET00364 | |
| 0.044 | 0.016 | 0.044 | Vasopressin 1 antagonist | |||
| 0.041 | 0.015 | 0.041 | Vasopressin 1A antagonist | 0.025 0.023 DBMET00364 | ||
| 0.058 | 0.031 | 0.058 | NMDA 2A receptor antagonist | |||
| 0.053 | 0.027 | 0.062 | Opioid mu receptor agonist | 0.062 0.023 DBMET00364 | DBMET00364 | |
| 0.128 | 0.102 | 0.128 | NOS3 expression enhancer | |||
| 0.034 | 0.009 | 0.034 | DNA polymerase III inhibitor | |||
| 0.086 | 0.061 | 0.119 | Interleukin 5 antagonist | 0.119 0.024 DBMET00364 | DBMET00364 | |
| 0.034 | 0.009 | 0.034 | Kainate receptor 1 antagonist | 0.018 0.017 DBMET00364 | ||
| 0.029 | 0.005 | 0.032 | Somatostatin 2 agonist | 0.032 0.005 DBMET00364 | DBMET00364 | |
| 0.055 | 0.031 | 0.055 | CC chemokine 5 receptor antagonist | |||
| 0.081 | 0.057 | 0.081 | Phosphodiesterase 11A inhibitor | |||
| 0.081 | 0.057 | 0.081 | Phosphodiesterase XI inhibitor | |||
| 0.034 | 0.011 | 0.034 | CC chemokine 1 receptor antagonist | |||
| 0.071 | 0.051 | 0.071 | Calcium channel L-type blocker | |||
| 0.03 | 0.011 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.061 | 0.042 | 0.061 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.114 | 0.095 | 0.114 | Calcium channel blocker | |||
| 0.272 | 0.253 | 0.328 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.328 0.177 DBMET00364 | DBMET00364 | |
| 0.043 | 0.025 | 0.047 | Neurokinin 1 antagonist | 0.047 0.021 DBMET00364 | DBMET00364 | |
| 0.029 | 0.014 | 0.029 | Dopamine autoreceptor agonist | |||
| 0.077 | 0.062 | 0.077 | Adrenaline agonist | |||
| 0.034 | 0.02 | 0.034 | Vanilloid 4 antagonist | |||
| 0.031 | 0.017 | 0.031 | Sigma 1 receptor antagonist | |||
| 0.117 | 0.104 | 0.117 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.023 | 0.009 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.043 | 0.03 | 0.044 | Opioid kappa receptor agonist | 0.044 0.03 DBMET00364 | DBMET00364 | |
| 0.039 | 0.028 | 0.039 | Substance P antagonist | |||
| 0.048 | 0.037 | 0.048 | Bromodomain-containing protein 3 inhibitor | |||
| 0.047 | 0.039 | 0.049 | CC chemokine receptor 2B antagonist | 0.049 0.034 DBMET00364 | DBMET00364 | |
| 0.036 | 0.029 | 0.036 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.044 | 0.038 | 0.048 | AMPA receptor antagonist | 0.048 0.033 DBMET00364 | DBMET00364 | |
| 0.029 | 0.024 | 0.039 | Somatostatin agonist | 0.039 0.017 DBMET00364 | DBMET00364 | |
| 0.018 | 0.014 | 0.027 | Cathepsin S inhibitor | 0.027 0.009 DBMET00364 | DBMET00364 | |
| 0.013 | 0.009 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.049 | 0.046 | 0.049 | CC chemokine 2 receptor antagonist | |||
| 0.142 | 0.139 | 0.142 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.015 | 0.012 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.025 | 0.023 | 0.025 | 5 Hydroxytryptamine 1D agonist | |||
| 0.018 | 0.015 | 0.018 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.034 | 0.032 | 0.034 | ATM kinase inhibitor | |||
| 0.183 | 0.183 | 0.537 | Immunomodulator | 0.537 0.018 DBMET00364 | DBMET00364 | |
| 0.038 | 0.04 | 0.049 | GABA B receptor antagonist | 0.049 0.02 DBMET00364 | DBMET00364 | |
| 0.052 | 0.055 | 0.058 | Phosphodiesterase 1B inhibitor | 0.058 0.045 DBMET00364 | DBMET00364 | |
| 0.019 | 0.025 | 0.023 | Kainate receptor 4 antagonist | 0.023 0.019 DBMET00364 | DBMET00364 | |
| 0.029 | 0.036 | 0.12 | NMDA receptor subunit 3A antagonist | 0.12 0.007 DBMET00364 | DBMET00364 | |
| 0.045 | 0.053 | 0.157 | GABA receptor antagonist | 0.157 0.009 DBMET00364 | DBMET00364 | |
| 0.063 | 0.073 | 0.074 | Adenosine A3 receptor antagonist | 0.074 0.051 DBMET00364 | DBMET00364 | |
| 0.011 | 0.022 | 0.023 | Progesterone agonist | 0.023 0.009 DBMET00364 | DBMET00364 | |
| 0.032 | 0.049 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.029 DBMET00364 | DBMET00364 | |
| 0.038 | 0.062 | 0.079 | Histamine H4 receptor antagonist | 0.079 0.009 DBMET00364 | DBMET00364 | |
| 0.024 | 0.05 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 DBMET00364 | DBMET00364 | |
| 0.036 | 0.062 | 0.064 | 5 Hydroxytryptamine 2 agonist | 0.064 0.023 DBMET00364 | DBMET00364 | |
| 0.171 | 0.198 | 0.229 | Tyrosine 3 hydroxylase inhibitor | 0.229 0.091 DBMET00364 | DBMET00364 | |
| 0.027 | 0.055 | 0.037 | Somatostatin 4 agonist | 0.037 0.025 DBMET00364 | DBMET00364 | |
| 0.036 | 0.07 | 0.125 | GABA A receptor antagonist | 0.125 0.012 DBMET00364 | DBMET00364 | |
| 0.077 | 0.116 | 0.09 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET00364 | DBMET00364 | |
| 0.034 | 0.073 | 0.091 | Neuropeptide Y5 antagonist | 0.091 0.018 DBMET00364 | DBMET00364 | |
| 0.039 | 0.079 | 0.072 | 5 Hydroxytryptamine 2A agonist | 0.072 0.035 DBMET00364 | DBMET00364 | |
| 0.049 | 0.093 | 0.073 | Phosphodiesterase 1C inhibitor | 0.073 0.026 DBMET00364 | DBMET00364 | |
| 0.033 | 0.08 | 0.055 | Nicotinic neuronal receptor agonist | 0.055 0.04 DBMET00364 | DBMET00364 | |
| 0.059 | 0.111 | 0.095 | Antineoplastic alkaloid | 0.095 0.051 DBMET00364 | DBMET00364 | |
| 0.018 | 0.071 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.021 DBMET00364 | DBMET00364 | |
| 0.027 | 0.081 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.016 DBMET00364 | DBMET00364 | |
| 0.033 | 0.096 | 0.05 | Myc inhibitor | 0.05 0.044 DBMET00364 | DBMET00364 | |
| 0.023 | 0.091 | 0.141 | NMDA receptor subunit 3B antagonist | 0.141 0.007 DBMET00364 | DBMET00364 | |
| 0.136 | 0.211 | 0.352 | 5 Hydroxytryptamine release stimulant | 0.352 0.056 DBMET00364 | DBMET00364 | |
| 0.014 | 0.09 | 0.092 | 5 Hydroxytryptamine 2C agonist | 0.092 0.009 DBMET00364 | DBMET00364 | |
| 0.019 | 0.102 | 0.048 | Dopamine D5 agonist | 0.048 0.019 DBMET00364 | DBMET00364 | |
| 0.029 | 0.113 | 0.043 | Alpha 1L adrenoreceptor agonist | 0.043 0.028 DBMET00364 | DBMET00364 | |
| 0.034 | 0.12 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET00364 | DBMET00364 | |
| 0.025 | 0.112 | 0.069 | Opioid delta receptor antagonist | 0.069 0.041 DBMET00364 | DBMET00364 | |
| 0.029 | 0.118 | 0.05 | Nicotinic receptor alpha4 subunit antagonist | 0.05 0.032 DBMET00364 | DBMET00364 | |
| 0.006 | 0.095 | 0.022 | Nicotinic alpha4 receptor agonist | 0.022 0.006 DBMET00364 | DBMET00364 | |
| 0.023 | 0.116 | 0.057 | 5 Hydroxytryptamine 2B agonist | 0.057 0.009 DBMET00364 | DBMET00364 | |
| 0.031 | 0.124 | 0.084 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 DBMET00364 | DBMET00364 | |
| 0.078 | 0.171 | 0.237 | Interleukin 4 antagonist | 0.237 0.015 DBMET00364 | DBMET00364 | |
| 0.03 | 0.127 | 0.16 | Phosphodiesterase III inhibitor | 0.16 0.009 DBMET00364 | DBMET00364 | |
| 0.101 | 0.201 | 0.129 | Pregnane X receptor agonist | 0.129 0.103 DBMET00364 | DBMET00364 | |
| 0.091 | 0.193 | 0.152 | Polo-like kinase-3 inhibitor | 0.152 0.082 DBMET00364 | DBMET00364 | |
| 0.057 | 0.159 | 0.098 | NADH dehydrogenase inhibitor | 0.098 0.046 DBMET00364 | DBMET00364 | |
| 0.045 | 0.15 | 0.086 | Glycine receptor antagonist | 0.086 0.048 DBMET00364 | DBMET00364 | |
| 0.025 | 0.134 | 0.045 | Benzodiazepine antagonist | 0.045 0.04 DBMET00364 | DBMET00364 | |
| 0.084 | 0.194 | 0.124 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.124 0.122 DBMET00364 | DBMET00364 | |
| 0.059 | 0.172 | 0.096 | Electrolyte absorption antagonist | 0.096 0.063 DBMET00364 | DBMET00364 | |
| 0.123 | 0.24 | 0.173 | Superoxide dismutase inhibitor | 0.173 0.151 DBMET00364 | DBMET00364 | |
| 0.156 | 0.276 | 0.278 | GABA C receptor rho-3 antagonist | 0.278 0.131 DBMET00364 | DBMET00364 | |
| 0.058 | 0.188 | 0.116 | Ribosomal protein S6 kinase inhibitor | 0.116 0.094 DBMET00364 | DBMET00364 | |
| 0.024 | 0.154 | 0.077 | Cyclin-dependent kinase 6 inhibitor | 0.077 0.024 DBMET00364 | DBMET00364 | |
| 0.151 | 0.288 | 0.321 | 5 Hydroxytryptamine uptake stimulant | 0.321 0.035 DBMET00364 | DBMET00364 | |
| 0.007 | 0.154 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.034 0.013 DBMET00364 | DBMET00364 | |
| 0.007 | 0.159 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET00364 | DBMET00364 | |
| 0.022 | 0.187 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 DBMET00364 | DBMET00364 | |
| 0.152 | 0.357 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 DBMET00364 | DBMET00364 | |
| 0.035 | 0.276 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.042 DBMET00364 | DBMET00364 | |
| 0.035 | 0.277 | 0.157 | GABA C receptor agonist | 0.157 0.031 DBMET00364 | DBMET00364 | |
| 0.09 | 0.356 | 0.189 | MAP-kinase-activated kinase 5 inhibitor | 0.189 0.118 DBMET00364 | DBMET00364 | |
| 0.02 | 0.308 | 0.05 | Topoisomerase II beta inhibitor | 0.05 0.033 DBMET00364 | DBMET00364 | |
| 0.045 | 0.335 | 0.132 | Interleukin 1 antagonist | 0.132 0.074 DBMET00364 | DBMET00364 | |
| 0.033 | 0.338 | 0.105 | GABA C receptor rho-1 antagonist | 0.105 0.056 DBMET00364 | DBMET00364 | |
| 0.007 | 0.349 | 0.068 | Phosphodiesterase 2A inhibitor | 0.068 0.019 DBMET00364 | DBMET00364 | |
| 0.006 | 0.349 | 0.076 | Phosphodiesterase II inhibitor | 0.076 0.02 DBMET00364 | DBMET00364 | |
| 0.04 | 0.403 | 0.16 | Interleukin antagonist | 0.16 0.11 DBMET00364 | DBMET00364 | |
| 0.01 | 0.376 | 0.056 | Cyclin A1 inhibitor | 0.056 0.046 DBMET00364 | DBMET00364 | |
| 0.023 | 0.395 | 0.121 | GABA C receptor antagonist | 0.121 0.051 DBMET00364 | DBMET00364 | |
| 0.034 | 0.426 | 0.096 | Activin receptor-like kinase 4 inhibitor | 0.096 0.093 DBMET00364 | DBMET00364 | |
| 0.005 | 0.506 | 0.213 | Phosphodiesterase 3B inhibitor | 0.213 0.005 DBMET00364 | DBMET00364 | |
| 0.022 | 0.701 | 0.075 | Heme oxygenase stimulant | 0.075 0.019 DBMET00364 | DBMET00364 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |